Patents
Patents for C07D 249 - Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms (17,749)
04/2010
04/28/2010CN1706834B New triadimenol derivative with antifungal activity and its preparation process and medicinal use
04/27/2010US7705159 combining a 4-(halomethyl)benzonitrile with a metal salt of 1H-1,2,4triazole and a solvent selected from dimethylacetamide, N-methyl-2-pyrrolidone, thereby forming 4-[1-(1,2,4-triazolyl)methyl]benzonitrile; reacting formed intermediate with with 4-halobenzonitrile in presence of a base to form letrozole
04/27/2010US7705053 Benzamide derivative
04/27/2010US7705029 Acrylonitrile derivatives for inflammation and immune-related uses
04/22/2010WO2010045258A2 Spirocyclic gpr40 modulators
04/22/2010WO2010043849A1 Process for the preparation of rufinamide
04/22/2010WO2010012442A3 Insecticidal benzenedicarboxamide derivative
04/22/2010US20100099888 Process for the preparation of anticancer drugs
04/22/2010US20100099887 Process for the Preparation of Pure Anastrozole
04/22/2010US20100099725 Peroxisome proliferator activated receptor modulators
04/22/2010US20100099689 Methods of modulating ppar gamma-type receptors
04/22/2010US20100099682 Acetylene derivatives
04/22/2010CA2739888A1 Spirocyclic gpr40 modulators
04/22/2010CA2736703A1 Process for the preparation of rufinamide
04/21/2010EP2177594A1 Anti-wear agent, additive composition for lubricant, and lubricant composition
04/21/2010EP2176243A1 Ophthalmic lens materials containing chromophores that absorb both uv and short wavelength visible light
04/21/2010EP2176242A1 Ophthalmic lens materials containing chromophores that absorb both uv and short wavelength visible light
04/20/2010US7700622 Antiinflammatory agents; autoimmune disease; bone disorders; viricides; antiproliferative agents; antiarthritic agents
04/20/2010CA2510540C Triazole derivatives as inhibitors of 11-beta-hydroxysteroid dehydrogenase-1
04/15/2010WO2010042596A2 Photo-activated protecting groups
04/15/2010WO2010041748A1 Fluorene compound and use thereof for medical purposes
04/15/2010WO2010040718A1 Triazole and imidazole compounds, use thereof and agents containing them
04/15/2010WO2010040717A1 Triazole and imidazole compounds, use thereof and agents containing them
04/15/2010CA2737677A1 Triazole and imidazole compounds, their use and compositions comprising them
04/14/2010EP2173717A2 Novel glucokinase activators and methods of using same
04/14/2010EP1551799B1 Cyclohexyl sulphones as gamma-secretase inhibitors
04/14/2010CN101693698A Process for preparing 3, 4, 5-triamino-1, 2, 4-triazole dinitramide
04/13/2010US7696379 Acetylene derivatives
04/13/2010US7696358 Five-membered heterocyclyl tetracycline compounds and methods of use thereof
04/13/2010US7695643 Long wavelength shifted benzotriazole UV-absorbers and their use
04/08/2010US20100087464 Protein kinase inhibitors and methods for using thereof
04/08/2010US20100087321 Azolylmethyloxiranes, their use for Controlling Phytopathogenic Fungi, and Compositions Comprising Them
04/08/2010US20100086915 Detection of esr1 amplification in breast cancer
04/08/2010US20100086500 Ultraviolet light absorbing ketones of 2-(2-Hydroxyphenyl) benzotriazole
04/07/2010EP2172462A1 Method for production of 3-hydroxypropan-1-one compound, method for production of 2-propen-1-one compound, and method for production of isoxazoline compound
04/07/2010EP2172449A2 Process for the purification of Anastrazole
04/07/2010EP2170915A2 Spin transition material
04/07/2010EP2170823A1 N-(2-(hetaryl)aryl)arylsulfonamides and n-(2-(hetaryl)hetaryl)arylsulfonamides
04/07/2010EP2170822A2 Proton acceptor iminium/carbocation-type coupling agents
04/07/2010CN101691360A Preparation method of carbamyl benzotriazole
04/06/2010US7692025 such as anastrozole; solvent extraction; chromatography
04/06/2010CA2566108C Proline derivatives and their use as dipeptidyl peptidase iv inhibitors
04/06/2010CA2464846C Dibenzylamine compounds and pharmaceutical use thereof
04/06/2010CA2252536C Ethylene derivatives and pesticides containing said derivatives
04/01/2010WO2010036631A2 Compounds which selectively modulate the cb2 receptor
04/01/2010WO2010036630A2 Compounds which selectively modulate the cb2 receptor
04/01/2010WO2010017545A3 Triazole compounds that modulate hsp90 activity
04/01/2010US20100081827 2-(5-bromo-4-(4-cyclopropylnaphthalen-1-yl)-4h-1,2,4-triazol-3-ylthio)acetic acid and methyl ester
04/01/2010US20100081826 7-pyrrolyl tetracycline compounds and methods of use thereof
04/01/2010US20100081802 Synthesis of Phosphitylated Compounds Using a Quaternary Heterocyclic Activator
04/01/2010US20100081644 Compounds Which Selectively Modulate The CB2 Receptor
04/01/2010CA2737645A1 Compounds which selectively modulate the cb2 receptor
04/01/2010CA2737639A1 Compounds which selectively modulate the cb2 receptor
03/2010
03/31/2010EP2168951A1 Azolylmethylenehydrazine derivative and use thereof
03/31/2010EP1807393B1 Diarylsulfones as 5-ht2a antagonists
03/31/2010EP1620091B1 Inhibitors of glutaminyl cyclase
03/31/2010CN101684103A Compound with 1,2,4-triazole structure and preparation method and application thereof
03/30/2010US7687638 C-(3-Methyl-5-phenyl-3H-benzoimidazol-4-yl)-methylamine; diabetes, fasting plasma glucose (IFG), metabolic acidosis, ketosis, appetite regulation, obesity, immunosuppressants or cytokine release regulation, autoimmune diseases such as inflammatory bowel disease, multiple sclerosis and arthritis
03/30/2010US7687526 Benzo-fused compounds for use in treating metabolic disorders
03/30/2010US7687435 herbicides; act against broad-leaved weeds and grass weeds in crops such as wheat, rice, corn, soya and cotton without causing any significant damage to the crop plants
03/25/2010WO2010031848A1 Imidazole and triazole compounds, their use and agents containing the same
03/25/2010WO2010031847A1 Imidazole and triazole compounds, their use and agents containing the same
03/25/2010WO2010031843A1 Imidazole and triazole compounds, their use and agents containing the same
03/25/2010WO2010031842A1 Imidazole and triazole compounds, their use and agents containing the same
03/25/2010WO2010031721A1 Imidazole and triazole compounds, their use and agents containing the same
03/25/2010US20100076029 Compounds Which Selectively Modulate The CB2 Receptor
03/25/2010US20100075500 Metal polishing slurry and chemical mechanical polishing method
03/24/2010EP2164825A1 Di(hetero)arylcyclohexane derivatives, their preparation, their use and pharmaceutical compositions comprising them
03/24/2010CN101679370A Novel vanilloid receptor ligands and the use thereof for the production of pharmaceuticals
03/24/2010CN101679320A Process for preparing triazolones
03/24/2010CN101679319A Triazole compounds that modulate hsp90 activity
03/24/2010CN101679318A Development of molecular imaging probes for carbonic anhydrase-IX using click chemistry
03/24/2010CN101677970A Use of iron chelator for the treatment of myocardial infarction
03/23/2010US7683087 HIV infections; potent antiviral effects, particularly against mutated Reverse Transcriptases including K103N, Y181C and Y188L; 4-[2-(5-bromo-4-[7-methoxy-4-methylnaphthalen-1-yl]-4H-1,2,4-triazol-3-ylthio)acetamido]-3-chlorobenzoic acid
03/23/2010US7683059 Triazole compounds and uses related thereto
03/18/2010WO2010029926A1 Lighting cover
03/18/2010WO2010029066A1 Imidazole and triazole compounds, use thereof and agents containing said compounds
03/18/2010WO2010029065A1 Imidazole and triazole compounds, use thereof and agents containing said compounds
03/18/2010WO2010029029A1 Imidazole- und triazole compounds, their use, and agents containing the same
03/18/2010WO2010029003A1 Triazole compounds, use thereof, and agents containing same
03/18/2010WO2010029002A1 Triazole compounds, the use thereof and preparations containing these compounds
03/18/2010WO2010029001A1 Triazole compounds, use thereof, and agents containing same
03/18/2010WO2010029000A1 Triazole compounds, the use thereof and preparations containing these compounds
03/18/2010WO2010028986A1 Imidazole and triazole compounds, the use thereof and preparations containing these compounds
03/18/2010WO2010028985A1 Imidazole and triazole compounds as fungicides
03/18/2010WO2010028542A1 Pleuromutilin phosphate, its pharmaceutical composition, preparation method and uses thereof
03/18/2010WO2009153785A3 Crystalline modifications of prothioconazole
03/18/2010WO2009137651A8 Fungicidal substituted azoles
03/18/2010US20100069645 2-(5-bromo-4-(4-cyclopropylnaphthalen-1-yl)-4h-1,2,4-triazol-3-ylthio)acetic acid and methyl ester
03/18/2010US20100069644 Method of regio-selective synthesis of tri-substituted-1, 2, 3-triazoles
03/16/2010US7678831 2-{2-[3-(4-chlorophenyl)acryloyl]-4-methylphenoxy}-4-phenylbutanoic acid; Peroxisome Proliferator Activated Receptors (PPAR); diabetes, dyslipidemia and/or atherosclerosis
03/16/2010US7678830 inhibiting excessive nitric oxide or prostaglandin formation; cancer, Alzheimer's disease, Parkinson's disease, multiple sclerosis, amyotropic lateral sclerosis, rheumatoid arthritis, inflammatory bowel disease
03/11/2010WO2010028190A2 Compounds, compositions and methods of using same for modulating uric acid levels
03/11/2010WO2010026308A1 Method for preparing molecular imprint polymers (pem) by radical polymerisation
03/11/2010WO2010025558A1 Triazolium and imidazolium salts and uses thereof as antimalarials
03/11/2010WO2010011821A3 Dual-acting antihypertensive agents
03/11/2010US20100063064 3-(4-Fluoro-2-methyl-phenyl)-6-[5-methoxymethyl-4-(6-methoxy-pyridin-3-yl)-4H-[1,2,4]triazol-3-yl]-pyridazine; treatment of male sexual dysfunction, female sexual dysfunction, hypoactive sexual desire disorder, sexual arousal disorder, orgasmic disorder, sexual pain disorder, or premature ejaculation
03/11/2010US20100062972 Triazole compounds and uses related thereto
03/11/2010CA2736117A1 Compounds, compositions and methods of using same for modulating uric acid levels
03/10/2010EP2161291A2 Polymer
1 ... 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 ... 178